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Understanding the ontogeny of distinct hematopoietic cell types remains a challenge. In this issue,
Schraml et al. contribute to unraveling the complexity of a central component of the mononuclear
phagocyte system by using a new in vivo approach to trace the progeny of common dendritic cell
precursors.‘‘It was exciting when dendritic cells ap-
peared first as novel cells, and it remains
exciting that these cells represent a
novel force in medicine’’ (Steinman,
2012). After the original discovery of
dendritic cells (DCs) by Steinman and
Cohn in 1973, mainstream immunolo-
gists took several decades to fully recog-
nize the pivotal role of these myeloid leu-
kocytes. Today, DCs are well established
as central instigators and regulators of
both innate and adaptive immune
responses and have been used in pre-
clinical and clinical settings to treat
inflammatory diseases, alloimmunity, in-
fections, and cancer. Consequently, in
2011, Ralph Steinman was awarded the
Nobel Prize in Physiology or Medicine
for his discovery.
Strategically positioned in the skin, on
mucosal surfaces, and in other tissues
throughout the body, DCs are effective
sensors and phagocytic collectors of anti-genic material from a variety of sources,
including pathogens and cancer cells;
when DCs acquire antigen in a peripheral
tissue, they migrate to lymphoid organs,
where they function as potent activators
of antigen-specific lymphocytes (Merad
et al., 2013). However, not all DCs are
created equal; a growing number of sub-
sets have been identified in both mice
and humans that express distinct pheno-
typic markers and play specialized roles
in the immune system. A better under-
standing of the origins of these subsets
and the rules that determine their produc-
tion and function could not only generate
better insights in the intricacies of immune
regulation but may also reveal novel
avenues for therapeutic or prophylactic
immune modulation and vaccine devel-
opment; however, progress in this area
has been slow due to inherent limita-
tions in hitherto available biological tools
(Figure 1A).In this issue ofCell, Schraml et al. (2013)
report an in vivo lineage-tracing approach
that refines our understanding of DC sub-
set ontogeny. The authors employed an
in vivo genetic tagging strategy that spe-
cifically marks common DC precursors
and all of their progeny by constitutive
expression of enhanced yellow fluores-
cent protein (EYFP). This strategy not
only confirms and solidifies previously
held notions of the origin of several
DC subsets but also yields unexpected
discoveries, namely the identification
of common DC precursor-derived leu-
kocytes in the small intestine and kid-
ney. These DC subsets were previously
believed to be of monocyte origin
because earlier lineage-tracing studies
were unable to pinpoint their origin due
to technical limitations.
Historically, new cell types have been
defined based on morphology, surface
phenotype, and/or function, and it has
Figure 1. In Vivo Lineage-Tracing Strategies and Their Level of Resolution
(A) Different lineage-tracing strategies have been employed to investigate DC ontogeny. A common
approach involves the adoptive transfer of a purified precursor population (far left). A second method
makes use of selective depletion of a precursor population (middle left). A third strategy relies on the
detection of a fluorescent reporter to identify cells that express a specific gene, such as a transcription
factor (middle right). The new approach by Schraml et al. (2013) enables irreversible tagging of common
dendritic cell precursors and their progeny (far right).
(B) Example of population-based versus single-cell lineage-tracking strategies. The top row shows two
phenotypically homogeneous precursor populations that give rise to three distinctly differentiated progeny
(bottom row). Unlike population-based tracking, in which all progenitors express a single tag, tagging of
individual progenitors with unique labels allows the detection and quantification of heterogeneity in dif-
ferentiation potential between individual precursors.been assumed that similarities in these
characteristics are indicative of a com-
mon origin. Owing to recent technical
advances,many investigatorshaveshifted
their focus to analysis of transcription fac-
tor expression profiles. However,morpho-
logic, phenotypic, functional, and gene
expression characteristics of migratory
leukocytes, particularly DCs, can all be
influenced by environmental stimuli such
as tissue-specific homeostatic and/or
inflammation-induced signals, so similar-
ities in these parameters may not always
reflect descent from a common ancestor.
To faithfully track the progeny of a
selected precursor, several lineage-
tracing techniques have been developed
(Kretzschmar and Watt, 2012), including
a number of strategies that have been
applied in the DC field (Figure 1A). A com-
mon approach involves adoptive transfer
of purified precursors into (often irradi-
ated) mice, whereby the transferred cells
and their progeny carry a heritable marker
to distinguish them from host cells. How-
ever, it is difficult to ascertain whetherthe transferred progenitors can occupy
the same anatomic niches and access
the same differentiation and survival sig-
nals in the recipient that they encountered
in the donor; this raises uncertainty as to
whether the transferred cells’ differentia-
tion potential truly reflects their natural
state.
Another technique is based on the
selective depletion of defined precursors
in vivo. Subset-specific depletion can be
achieved in mice by inserting a comple-
mentary DNA (cDNA) for the diphtheria
toxin receptor (DTR) in a defined gene,
such as a transcription factor, that is
uniquely expressed in a cell type of inter-
est. Systemic treatment of the mutant
animals with diphtheria toxin (DT) can
selectively eliminate the DTR-expressing
cells, an approach that was recently
applied to DC precursors (Meredith et al.,
2012). Provided that all progenitors of in-
terest are depleted, this strategy faithfully
establishes ontogeny of the absent cell
type. However, it is challenging to identify
new lineagemembers, as the absenceof aCell 15cell type will only be noted if it was under
investigation in the first place.
Yet another technique involves tracking
of DCs in so-called ‘‘reporter mice,’’
whereby a suitable genetically encoded
tag, such as a fluorescent protein, is
placed under control of a lineage-specific
promoter (Satpathy et al., 2012). Any cell
that expresses the reporter gene above
the detection threshold can be identified.
Provided the activity of the chosen pro-
moter is faithfully restricted to a particular
lineage, essentially all lineage members
can be identified. However, any progeny
in which the promoter becomes inac-
tive (e.g., in response to environmental
changes) may be missed.
To overcome the limitations of these
traditional lineage-tracing strategies,
Schraml et al. (2013) generate a mouse
model in which common DC precursors
selectively express a bacterial enzyme,
Cre recombinase, which excises a
‘‘stop’’ signal in a constitutively active
genetic locus, thus enabling permanent
expression of EYFP from that locus.
Because the Cre-dependent activation
of EYFP expression is irreversible, the
fluorescent signal marks not only precur-
sors but also all of their progeny, irre-
spective of any subsequent changes in
transcription profile or phenotype. Illus-
trating the power of this approach, the
authors discover two EYFP-expressing
leukocyte subsets in the small intestine
and kidney that had not been previously
assigned to the DC lineage, thereby
refuting the long-held view that these
subsets originated from monocytes.
Despite the impressive sophistication
of this and other hematopoietic lineage-
tracing techniques, further methodo-
logical refinements are conceivable in
years to come. For example, large-scale
expression profiling may yield further
highly specific tools for in vivo tagging of
various progenitors, which could be com-
bined with inducible promoter systems to
enhance temporal resolution and tagg-
ing specificity. Furthermore, it should be
feasible to improve lineage-tracing tech-
niques to provide single-cell resolution of
precursor-progeny relationships. So far,
most fate-mapping studies in the DC line-
age have tracked the progeny of precur-
sor populations rather than individual
precursor cells (Figure 1B). Emphasizing
the importance of single-cell tracking,4, August 15, 2013 ª2013 Elsevier Inc. 721
recent studies have demonstrated that
individual phenotypically homogenous
hematopoietic progenitors can have high-
ly heterogeneous fates (Lu et al., 2011;
Naik et al., 2013; Buchholz et al., 2013;
Gerlach et al., 2013). In vivo lineage
tracing of single hematopoietic cells so
far has only been performed in adoptive
transfer settings either by transfer of
genetically tagged single cells or of cell
populations composed of individual cells
that each carry a unique and heritable
label, such as a congenic marker, fluores-
cent protein, or DNA barcode (that is, a
random noncoding DNA sequence).
Looking to the future, the combination
of specific in vivo tagging technologies
with single-cell resolution strategies may
ultimately lead to a deeper understanding
of the origin, pedigree, and function of722 Cell 154, August 15, 2013 ª2013 Elseviemany cell types, including DC subsets.
Thus, 40 years after the initial discovery
of DCs, these multifaceted cells remain
an important and exciting object of inves-
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